(Q51826071)

13 April 2018

title

Utility of a commercial immunoblot kit (BAG-Borrelia blot) in the diagnosis of the preliminary stages of Lyme disease. (English)

1 reference

13 April 2018

main subject

Lyme disease

0 references

author name string

Beatriz Hernández-Novoa

1

1 reference

13 April 2018

Antonio Orduña

2

1 reference

13 April 2018

Miguel Angel Bratos

3

1 reference

13 April 2018

José Marí Eiros

4

1 reference

13 April 2018

José Miguel Fernández

5

1 reference

13 April 2018

M Purificación Gutiérrez

6

1 reference

13 April 2018

Pedro Alonso Alonso

7

1 reference

13 April 2018

M Angeles Mantecón

8

1 reference

13 April 2018

Ana Almaraz

9

1 reference

13 April 2018

José Antonio Oteo

10

1 reference

13 April 2018

Antonio Rodríguez-Torres

11

1 reference

13 April 2018

publication date

1 September 2003

1 reference

13 April 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

13 April 2018

volume

47

1 reference

13 April 2018

issue

1

1 reference

13 April 2018

page(s)

321-329

1 reference

13 April 2018

Antigenic cross-reactivity between Treponema pallidum and other pathogenic members of the family Spirochaetaceae

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Cross-reactive proteins of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Immune complexes from serum of patients with lyme disease contain Borrelia burgdorferi antigen and antigen-specific antibodies: potential use for improved testing

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Western blotting in the serodiagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Evaluation of a passive hemagglutination assay as screening test and of a recombinant immunoblot as confirmatory test for serological diagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Lyme borreliosis — Problems of serological diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

False-negative serology in patients with neuroborreliosis and the value of employing of different borrelial strains in serological assays

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Immunoblot analysis of antibody binding to polypeptides of Borrelia burgdorferi in children with different clinical manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

1 reference

7 January 2021

Use of the C3H/He Lyme disease mouse model for the recovery of a Spanish isolate of Borrelia garinii from erythema migrans lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Laboratory testing for Lyme disease: possibilities and practicalities

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Identification of Borrelia burgdorferi sensu lato species in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Borrelia burgdorferi-specific immune complexes in acute Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Diagnosing early Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Summary of the fourth international symposium on Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

The early clinical manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Monoclonal antibody to native P39 protein from Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

Diagnostic and biological significance of anti-p41 IgM antibodies against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2803%2900111-1

7 January 2021

10.1016/S0732-8893(03)00111-1

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

12967745

1 reference

13 April 2018